Scholarlink

<p>Antithrombotic treatment is the backbone to prevent ischemic events in interventional cardiology; however, antithrombotic medication enhances the risk of bleeding. Oncological diseases are frequently associated with thrombocytopenia. The optimal antithrombotic regimen if these patients undergo interventional procedures is unknown. Hence, this consensus statement aims to provide a&#xa0;clinical guide to antithrombotic treatment options in these patients. As there are no sufficient data these recommendations are based on expert opinions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Antithrombotische Therapie für kardiologische Eingriffe bei Patienten mit Thrombozytopenie bei onkologischen Erkrankungen

  • 期刊论文

  • 发表日期：

    2025年9月3日

查看全文
  • David Naguib,
  • Tamam Bakchoul,
  • Sascha Dietrich,
  • Tobias Geisler,
  • Holger Hackstein,
  • Alexander Kille,
  • Steffen Koschmieder,
  • Lorenz H. Lehmann,
  • Axel Linke,
  • Tobias Petzold,
  • Roman Pfister,
  • Christoph B. Olivier,
  • Heiko Rühl,
  • Andreas Tiede,
  • Karolin Trautmann-Grill,
  • Willibald Hochholzer,
  • Amin Polzin

摘要

Antithrombotic treatment is the backbone to prevent ischemic events in interventional cardiology; however, antithrombotic medication enhances the risk of bleeding. Oncological diseases are frequently associated with thrombocytopenia. The optimal antithrombotic regimen if these patients undergo interventional procedures is unknown. Hence, this consensus statement aims to provide a clinical guide to antithrombotic treatment options in these patients. As there are no sufficient data these recommendations are based on expert opinions.